These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 11202196
1. [Combination chemotherapy with hexamethylamine (Hexalen, Altretamine, Hexastat) and sarcolysine in advanced ovarian carcinoma]. Gershanovich ML, Livshits ME, Antipenkova VI. Vopr Onkol; 2000; 46(5):604-7. PubMed ID: 11202196 [Abstract] [Full Text] [Related]
2. Phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer: a Southwest Oncology Group trial (SWOG-9326). Rothenberg ML, Liu PY, Wilczynski S, Hannigan EV, Weiner SA, Weiss GR, Hunter VJ, Chapman JA, Tiersten A, Kohler PC, Alberts DS. Gynecol Oncol; 2001 Aug; 82(2):317-22. PubMed ID: 11531286 [Abstract] [Full Text] [Related]
3. Altretamine (hexamethylmelamine) in platinum-resistant and platinum-refractory ovarian cancer: a Gynecologic Oncology Group phase II trial. Markman M, Blessing JA, Moore D, Ball H, Lentz SS. Gynecol Oncol; 1998 Jun; 69(3):226-9. PubMed ID: 9648592 [Abstract] [Full Text] [Related]
5. Random study of hexamethylmelamine, 5-fluorouracil, and melphalan in treatment of advanced carcinoma of the ovary. Smith JP, Rutledge FN. Natl Cancer Inst Monogr; 1975 Oct; 42():169-72. PubMed ID: 825778 [Abstract] [Full Text] [Related]
6. Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary. Dusenbery KE, Bellairs EE, Potish RA, Twiggs LB, Boente MP. Gynecol Oncol; 2005 Feb; 96(2):307-13. PubMed ID: 15661213 [Abstract] [Full Text] [Related]
7. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Müller H, Nakchbandi V, Chatzisavvidis I, von Voigt C. Hepatogastroenterology; 2003 Feb; 50(54):1919-26. PubMed ID: 14696433 [Abstract] [Full Text] [Related]
8. [The use of Hexalen (Altretamin, hexamethyl melamine) in chemotherapy of extensive carcinoma of the ovaries]. Gershanovich ML, Livshits ME, Makhnova EV. Vopr Onkol; 2000 Feb; 46(4):480-4. PubMed ID: 11147431 [No Abstract] [Full Text] [Related]
9. Phase II study of melphalan as a single-agent infused over a 24-hour period with individual adapted dosing in patients with recurrent epithelial ovarian cancer. Mougenot P, Fabbro M, Bressolle F, Pouessel D, Culine S, Pinguet F. Oncol Rep; 2006 Jan; 15(1):237-41. PubMed ID: 16328062 [Abstract] [Full Text] [Related]
14. Chemotherapy in advanced ovarian cancer. Smith JP, Rutledge FN. Natl Cancer Inst Monogr; 1975 Oct; 42():141-3. PubMed ID: 825776 [Abstract] [Full Text] [Related]
15. Evaluation of a hexamethylmelamine and 5-fluorouracil combination in the treatment of advanced ovarian carcinoma. Kardinal CG, Luce JK. Cancer Treat Rep; 1977 Dec; 61(9):1691-3. PubMed ID: 413624 [Abstract] [Full Text] [Related]
20. Melphalan as a treatment for BRCA-related ovarian carcinoma: can you teach an old drug new tricks? Osher DJ, Kushner YB, Arseneau J, Foulkes WD. J Clin Pathol; 2011 Oct; 64(10):924-6. PubMed ID: 21378390 [Abstract] [Full Text] [Related] Page: [Next] [New Search]